PVCT President Dominic Rodrigues Buys 45,860 Shares

PVCT's President, Dominic Rodrigues, made headlines with his recent purchase of 45,860 shares on June 30, 2026. The transaction wasn't part of a pre-planned trading program. This move comes as PVCT shares traded at $0.07 on Wednesday.

Insider Buying and Selling at Provectus Biopharmaceuticals, Inc.

Several insiders were active in PVCT's stock recently. Alongside Dominic Rodrigues, Lacey John III and Bailey Webster each bought 48,917 shares on June 30, 2026. On the same date, CEO Edward Pershing also increased his holdings by purchasing 9,436 shares, although he had sold the same amount earlier in June. Pershing further added 5,242 shares to his holdings on May 28, 2026.

Other Institutional Activity in PVCT

In recent institutional activity, Atlas Wealth LLC opened a new position in PVCT, adding 19,620 shares worth approximately $999. Meanwhile, Home Federal Bank of Tennessee maintained its holdings at 100,000 shares valued at $5,100. Wealth Preservation Advisors, LLC also kept its position steady with 52,600 shares, valued at about $2,677. Academy Capital Management held onto its 20,000 shares, worth roughly $1,018, and Financial Symmetry Inc. stayed with 10,191 shares valued at $581.

Bottom Line

Dominic Rodrigues' purchase of PVCT shares highlights ongoing insider confidence in the company. While shares traded at $0.07, the active buying by insiders could be a point of interest for investors. Institutional activities also reveal a mix of new positions and steady holdings, suggesting varied strategies among major holders. As always, these insider transactions are disclosed after the fact and may not reflect the current status.